Registry of patients with atrial fibrillation undergoing catheter-based ablation
Official title: Swiss Atrial Fibrillation Pulmonary Vein Isolation Registry
Run by University Hospital, Basel, Switzerland · NCT03718364 · Data updated 2026-11-12
This study is tracking patients with atrial fibrillation who are getting a specific heart procedure to see how well it works over time.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 3000 (estimated) |
| Sponsor | University Hospital, Basel, Switzerland Academic / other |
| Locations | 2 sites (Basel and 1 other locations) |
| Status | Recruiting |
| Started | July 1, 2010 |
| Main results expected | December 2035 |
| Study ends | December 2035 |
| Registry record updated | February 18, 2025 |
| Trial ID | NCT03718364 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this registry are patients who are undergoing catheter-based ablation for atrial fibrillation.
✕Probably not a fit
Patients who are not able or willing to participate in the study will not benefit from the findings.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This registry collects data from patients with atrial fibrillation who are undergoing catheter-based ablation, specifically focusing on pulmonary vein isolation. The aim is to determine the long-term success rates of this procedure and to evaluate various factors that may influence these outcomes. By tracking patient progress and outcomes over time, the registry seeks to provide valuable insights into the effectiveness of catheter-based ablation for atrial fibrillation. This observational approach allows for a comprehensive understanding of real-world results in a clinical setting.
Why it matters
Potential benefit: If successful, this registry could provide critical information that enhances the treatment strategies for patients with atrial fibrillation, potentially leading to improved long-term outcomes.
How similar studies have gone: Other studies have shown success with similar observational approaches in evaluating the effectiveness of catheter-based ablation for atrial fibrillation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients undergoing catheter-based ablation of atrial fibrillation (pulmonary vein isolation) Exclusion Criteria: * Patients not able or willing to participate in this study
Where it's running
-
Cardiology/Electrophysiology, University Hospital Basel
Basel, Switzerland Recruiting -
University Hospital Bern
Bern, Switzerland Recruiting
Study contacts
- Principal investigator: Michael Kuehne, MD — Cardiology/Electrophysiology, University Hospital Basel
- Study coordinator: Michael Kuehne, MD
- Email: michael.kuehne@usb.ch
- Phone: +41 61 328 74 71
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.